Embla Medical hf Past Earnings Performance
Past criteria checks 5/6
Embla Medical hf has been growing earnings at an average annual rate of 6%, while the Medical Equipment industry saw earnings growing at 9.7% annually. Revenues have been growing at an average rate of 4.9% per year. Embla Medical hf's return on equity is 8.8%, and it has net margins of 8.2%.
Key information
6.0%
Earnings growth rate
5.6%
EPS growth rate
| Medical Equipment Industry Growth | -1.7% |
| Revenue growth rate | 4.9% |
| Return on equity | 8.8% |
| Net Margin | 8.2% |
| Next Earnings Update | 05 Feb 2025 |
Recent past performance updates
Recent updates
Results: Embla Medical hf. Beat Earnings Expectations And Analysts Now Have New Forecasts
Oct 25
Estimating The Intrinsic Value Of Embla Medical hf. (CPH:EMBLA)
Oct 17Do Embla Medical hf's (CPH:EMBLA) Earnings Warrant Your Attention?
Oct 02Embla Medical hf.'s (CPH:EMBLA) Share Price Matching Investor Opinion
Aug 22Earnings Beat: Embla Medical hf. Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models
Jul 26Calculating The Fair Value Of Embla Medical hf. (CPH:EMBLA)
Jul 17Market Participants Recognise Embla Medical hf.'s (CPH:EMBLA) Earnings
May 14Embla Medical hf. Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now
Apr 26A Look At The Fair Value Of Embla Medical hf. (CPH:OSSR)
Apr 10Is Össur hf (CPH:OSSR) Using Too Much Debt?
Mar 23Why Investors Shouldn't Be Surprised By Össur hf.'s (CPH:OSSR) P/E
Jan 21Calculating The Intrinsic Value Of Össur hf. (CPH:OSSR)
Jan 03Össur hf (CPH:OSSR) Seems To Use Debt Quite Sensibly
Nov 28Returns On Capital Signal Tricky Times Ahead For Össur hf (CPH:OSSR)
Nov 08A Look At The Fair Value Of Össur hf. (CPH:OSSR)
Sep 23We Think Össur hf (CPH:OSSR) Is Taking Some Risk With Its Debt
Aug 21Össur hf (CPH:OSSR) May Have Issues Allocating Its Capital
Jul 18Össur hf.'s (CPH:OSSR) Intrinsic Value Is Potentially 19% Below Its Share Price
Jun 14Össur hf (CPH:OSSR) Seems To Use Debt Quite Sensibly
May 19Össur hf (CPH:OSSR) Might Be Having Difficulty Using Its Capital Effectively
Mar 14A Look At The Intrinsic Value Of Össur hf. (CPH:OSSR)
Jan 21These 4 Measures Indicate That Össur hf (CPH:OSSR) Is Using Debt Reasonably Well
Dec 22There Are Reasons To Feel Uneasy About Össur hf's (CPH:OSSR) Returns On Capital
Dec 07Are Investors Undervaluing Össur hf. (CPH:OSSR) By 37%?
Sep 21Returns On Capital Signal Tricky Times Ahead For Össur hf (CPH:OSSR)
Sep 02Össur hf (CPH:OSSR) Seems To Use Debt Quite Sensibly
Aug 16Össur hf.'s (CPH:OSSR) Intrinsic Value Is Potentially 42% Above Its Share Price
Jun 16Össur hf (CPH:OSSR) Will Want To Turn Around Its Return Trends
Jun 01Does Össur hf (CPH:OSSR) Have A Healthy Balance Sheet?
May 08Össur hf (CPH:OSSR) Will Be Hoping To Turn Its Returns On Capital Around
Feb 22Analysts Have Made A Financial Statement On Össur hf.'s (CPH:OSSR) Yearly Report
Feb 03Calculating The Fair Value Of Össur hf. (CPH:OSSR)
Nov 25Returns On Capital Signal Tricky Times Ahead For Össur hf (CPH:OSSR)
Oct 17Is Össur hf (CPH:OSSR) A Risky Investment?
Sep 28Calculating The Fair Value Of Össur hf. (CPH:OSSR)
Aug 21Össur hf (CPH:OSSR) Might Be Having Difficulty Using Its Capital Effectively
Jul 11Here's Why Össur hf (CPH:OSSR) Can Manage Its Debt Responsibly
May 28Calculating The Fair Value Of Össur hf. (CPH:OSSR)
May 07There Are Reasons To Feel Uneasy About Össur hf's (CPH:OSSR) Returns On Capital
Mar 25We Think The Compensation For Össur hf.'s (CPH:OSSR) CEO Looks About Right
Mar 02We Think Össur hf (CPH:OSSR) Can Stay On Top Of Its Debt
Feb 22Does The Market Have A Low Tolerance For Össur hf.'s (CPH:OSSR) Mixed Fundamentals?
Feb 09Revenue & Expenses Breakdown
Revenue & Expenses Breakdown
How Embla Medical hf makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 30 Sep 24 | 840 | 69 | 375 | 40 |
| 30 Jun 24 | 820 | 61 | 371 | 39 |
| 31 Mar 24 | 804 | 57 | 368 | 38 |
| 31 Dec 23 | 786 | 58 | 360 | 38 |
| 30 Sep 23 | 766 | 52 | 353 | 37 |
| 30 Jun 23 | 750 | 45 | 354 | 36 |
| 31 Mar 23 | 730 | 43 | 345 | 34 |
| 31 Dec 22 | 719 | 43 | 339 | 34 |
| 30 Sep 22 | 715 | 47 | 339 | 34 |
| 30 Jun 22 | 719 | 57 | 331 | 33 |
| 31 Mar 22 | 728 | 62 | 331 | 34 |
| 31 Dec 21 | 719 | 64 | 328 | 32 |
| 30 Sep 21 | 701 | 50 | 323 | 32 |
| 30 Jun 21 | 692 | 48 | 318 | 31 |
| 31 Mar 21 | 637 | 11 | 308 | 31 |
| 31 Dec 20 | 630 | 6 | 307 | 31 |
| 30 Sep 20 | 639 | 20 | 303 | 30 |
| 30 Jun 20 | 635 | 19 | 308 | 30 |
| 31 Mar 20 | 680 | 59 | 311 | 31 |
| 31 Dec 19 | 686 | 66 | 308 | 31 |
| 30 Sep 19 | 675 | 83 | 296 | 31 |
| 30 Jun 19 | 652 | 85 | 284 | 31 |
| 31 Mar 19 | 631 | 83 | 274 | 31 |
| 31 Dec 18 | 613 | 80 | 265 | 31 |
| 30 Sep 18 | 599 | 69 | 259 | 31 |
| 30 Jun 18 | 593 | 64 | 254 | 31 |
| 31 Mar 18 | 579 | 58 | 252 | 30 |
| 31 Dec 17 | 569 | 58 | 245 | 29 |
| 30 Sep 17 | 553 | 49 | 246 | 29 |
| 30 Jun 17 | 543 | 51 | 239 | 27 |
| 31 Mar 17 | 538 | 52 | 240 | 25 |
| 31 Dec 16 | 521 | 51 | 233 | 23 |
| 30 Sep 16 | 507 | 49 | 227 | 21 |
| 30 Jun 16 | 495 | 50 | 219 | 20 |
| 31 Mar 16 | 483 | 51 | 209 | 19 |
| 31 Dec 15 | 483 | 51 | 208 | 18 |
| 30 Sep 15 | 488 | 54 | 209 | 18 |
| 30 Jun 15 | 497 | 55 | 213 | 18 |
| 31 Mar 15 | 502 | 57 | 214 | 19 |
| 31 Dec 14 | 509 | 59 | 218 | 19 |
| 30 Sep 14 | 509 | 58 | 217 | 20 |
| 30 Jun 14 | 487 | 55 | 207 | 20 |
| 31 Mar 14 | 460 | 46 | 199 | 21 |
| 31 Dec 13 | 436 | 40 | 189 | 22 |
Quality Earnings: EMBLA has high quality earnings.
Growing Profit Margin: EMBLA's current net profit margins (8.2%) are higher than last year (6.8%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: EMBLA's earnings have grown by 6% per year over the past 5 years.
Accelerating Growth: EMBLA's earnings growth over the past year (32.1%) exceeds its 5-year average (6% per year).
Earnings vs Industry: EMBLA earnings growth over the past year (32.1%) exceeded the Medical Equipment industry 13%.
Return on Equity
High ROE: EMBLA's Return on Equity (8.8%) is considered low.